← Leaderboards
Elwood E. Reynolds
Mandalmed, Inc.
$1,066,859
Attributed
$1,066,859
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $382.1K · FY2005–08$500K$375K$250K$125K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$1,066,859 · 3
By mechanism
R44$725,129 · 1
R43$341,730 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Administration, Oral”
- Daniel R Kuritzkes · Brigham And Women'S Hospital$101,405,551
- Constance Ann Benson · University Of California, San Diego$93,029,470
- Robert A Wood · Johns Hopkins University$48,880,748
- Thierry Diagana · University Of Texas Med Br Galveston$37,506,320
- Vineet D Menachery · Univ Of North Carolina Chapel Hill$37,506,320
- David Heimbrook · Leidos Biomedical Research, Inc.$31,978,469
Research focus
Administration, OralAlbuminsAlbuminuriaAmericanAnimal ModelAntioxidantsAortaBiological AvailabilityBlood VesselsCaringChemistry, PharmaceuticalChronicClinical Trials, Phase IClinical Trials, Phase IiCollagen Type IvComplications Of Diabetes MellitusCostDailyDb/Db MouseDepositionDiabetes MellitusDiabetes Mellitus, Insulin-DependentDiabetes Mellitus, Non-Insulin-DependentAcetylcholine
Grant awards (4)
NO-donor/SOD-mimetics for diabetic nephropathy$343,045
R44 · FY2008 · DK · contact PI
NO-donor/SOD-mimetics for diabetic nephropathy$382,084
R44 · FY2007 · DK · contact PI
Novel SOD-mimetics for type 1 diabetes$207,730
R43 · FY2006 · DK · contact PI
NO-donor/SOD-mimetics for diabetic nephropathy$134,000
R43 · FY2005 · DK